| Literature DB >> 25671154 |
Saban Kalay1, Zehra Yilmaz1, Ozlem Sen1, Melis Emanet1, Emine Kazanc1, Mustafa Çulha1.
Abstract
Boron nitride nanotubes (BNNTs) have been increasingly investigated for use in a wide range of applications due to their unique physicochemical properties including high hydrophobicity, heat and electrical insulation, resistance to oxidation, and hydrogen storage capacity. They are also valued for their possible medical and biomedical applications including drug delivery, use in biomaterials, and neutron capture therapy. In this review, BNNT synthesis methods and the surface modification strategies are first discussed, and then their toxicity and application studies are summarized. Finally, a perspective for the future use of these novel materials is discussed.Entities:
Keywords: boron nitride nanotubes; chemical modifications; medical applications; synthesis methods; toxicity
Year: 2015 PMID: 25671154 PMCID: PMC4311706 DOI: 10.3762/bjnano.6.9
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Reaction conditions, growth mechanisms and applications of BNNTs reported in literature.a
| Precursor | Substrate | Method | Growth mechanism | Physical properties | Modification | Application | Ref. | |
| B, h-BN, NH3 | <1100; | iron deposits alumina | ball milling (20 h), CVD | base-growth | 40–100 nm diam., bamboo-like | – | – | [ |
| 1200; | 40–100 nm diam., cylindrical shape | |||||||
| B:FeO:MgO (2:1:1), NH3 | 1200; | Si/SiO2 | mechanic. mixed CVD | base-growth | 30 nm diam., random direction, closed tip ends | – | – | [ |
| 1300; | tip-growth | 60 nm diam., random direction, closed tip ends | ||||||
| 1400; | mixed-growth | 10 nm diam., flower-like, closed tip ends | ||||||
| B:FeO:MgO (1:1:1), NH3 | 1300; | tip-/base- | 100–500 nm diam., closed tip ends | |||||
| B:FeO:MgO (4:1:1), NH3 | 1300; | tip-/base- | 50–150 nm diam., closed tip ends | |||||
| B2O3, CaB6, Mg, NH3 | 1150; | – | CVD | base-growth | 150 nm diam., >10 µm length | – | – | [ |
| h-BN, N2 | 1250–1300; | – | ball milling (100 h), CVD | – | 30–60 nm diam., cylindirical shape, 500 nm length | covalent with NH4HCO3 | reinforced material for Al-matrix composite | [ |
| B, FeO, MgO | 1100–1700; | – | ball milling, CVD | metal catalytic growth | 50–80 nm diam., up to 10 µm length, straight nanowires | noncoval. polyaniline/ Pt/GO | amper. glucose biosensor | [ |
| B, iron particle, N2 | 1100; | Si/SiO2 | ball milling (50 h), CVD | metal catalytic growth | 50–200 nm diam., up to 1 mm length, bamboo-like | – | insulators for electromechanical systems | [ |
| MWCNT, H3BO3, NH3 | 1300; | – | substitution | – | 40–50 nm diam. | noncoval. trioctylam., tributylam., triphenyphos. | gel nanocomposite | [ |
| B, Co(NO3)2, N2, H2 | 1100; | stainless steel | ball milling, CVD | – | bamboo-like | – | superhydrophobic surface | [ |
| B, N2 | 1200; | – | ball milling (150 h), CVD | – | 20–50 nm diam. cylindrical, cylindrical capped by iron, bamboo-like | – | – | [ |
| KBH4, NH4CI, N2 | 1200–1300; | – | CVD | – | 10–30 nm diam., up to 5 µm length, bamboo-like | – | – | [ |
| B, Fe2O3, NH3 | 1200–1300; | – | CVD | – | 64–136 nm diam., bamboo-like | – | – | [ |
| MWCNT, H3BO3, NH3 | 1080; | – | substitution | – | 10–100 nm diam., 10 µm length | coval. PVA and HP-MEC | imp. mechanical performance of polymer | [ |
| ammon. borane, ferrocn., N2 | 1450; | graphite crucible (graphite paper inner line) | CVD | (large diam. catalyst) | 300 nm diam., 10 µm length, bamboo-like | – | – | [ |
| vapor–liquid– | 15–200 nm diam., 100 µm length, cylindrical shape | |||||||
| B, Fe2O3, NH3 | 600; | – | CVD | – | 20–60 nm diam. | – | hydrogen storage | [ |
| B, Fe3+-MCM-41, NH3 | 2.5–4 nm diam. | |||||||
| YB6, N2/Ar | – | – | arc discharge | mixed-growth | 4–10 nm diam., 4–6 µm length, closed or open tip | – | – | [ |
aPVA: polyvinyl alcohol, HP-MEC: hydroxypropyl methylcellulose.
Figure 1SEM images of BNNTs grown based on a CVD method. (a) Experimental setup, (b) stretching of dense BNNTs from the sample surface, (c) high magnification SEM image of BNNTs, (d) SEM images of slightly compressed BNNTs on a Si substrate, and (e) cross-sectional view of vertically aligned BNNTs. Figure adapted with permission from [56], copyright 2010 American Chemical Society.
Figure 2SEM images of the BNNTs products at the different reaction time and colemanite/catalyst ratios (w/w) after CVD application. The respective reaction time and colemanite/catalyst ratio (w/w) were (a) 30 min and 12:1, (b) 60 min and 12:1, (c) 120 min and 12:1, (d) 120 min and 32:1, and (e) 120 min and 8:1. (f) Boat surface after removal of the BNNTs, at 120 min and with a ratio of 12:1.
Figure 3Summary of chemical modification routes of BNNTs.
Figure 4Low (a) and high (b) magnification confocal images of fluorescently labeled, functionalized BNNTs, where red, green, and blue are the cytoskeletal actin, functionalized BNNT, and nuclei, respectively. Figure adapted with permission from [15], copyright 2012 Elsevier.
Figure 5TEM images of ferritin molecules immobilized onto BNNT surfaces (a), EDS spectrum of BNNTs with immobilized ferritin molecules (b), ferritin molecules on the surface and inside of a BNNT (c). Figure adapted with permission from [13], copyright 2005 American Chemical Society.
Toxicity behavior of the BNNTs on cultured cells and animals.
| Physical coating | In vitro / In vivo | Type of assay | Result | Ref. |
| PEI | SH-SY5Y | Trypan Blue, MTT | Nontoxic at 5 µg/mL | [ |
| glycol chitosan | SH-SY5Y | MTT, WST-1, Apo. kit, Image-IT Green ROS kit | Low toxicity <100 µg/mL | [ |
| PLC | Osteoblast cells ( | Real-time PCR | Increased cell growth | [ |
| nonfunctionalized | U87, T98, MCF-7, MRC-5 | MTT | Low toxicity <200 µg/mL | [ |
| nonfunctionalized | A549, RAW264.7, 3T3-L1, HEK293 | MTT, FMCA | Related to cell type | [ |
| glycol chitosan | HUVECs | Amido Black assay, Trypan Blue | Nontoxic <50 µg/mL | [ |
| glucosamine, PEG, chitosan | MRC-5 | MTT | Nontoxic <50 µg/mL | [ |
| PLL | C2C12 | Trypan Blue, MTT, LIVE/DEAD, annexin V-FITC | Low toxicity <10 µg/mL | [ |
| PLL | hOB | MTT | Low toxicity <10 µg/mL | [ |
| glycol chitosan | Rabbit | Blood tests | Nontoxic | [ |
Figure 6Scintigraphic image of radiolabeled, glycol chitosan BNNTs after (a) 30 min, (b) 1 h, and (c) 4 h after injection. Figure adapted with permission from [86], copyright 2012 Elsevier.
Figure 7Preparation process of PLC (left) and PLC–BNNTs (right) and (a,b) SEM images of a PLC–BNNT composite exhibiting improved mechanical properties due to BNNTs bridges (red). Figure adapted with permission from [75], copyright 2010 Acta Biomaterialia.
Figure 8Schematic representation of a humidity sensor test system with a single BNNT and a single BNNT–AgNPs. (a) SEM image (left) and EDS spectrum (right) and (b) TEM and HRTEM image of the BNNTs, (c) and (e) the SEM images with a single BNNT and single AgNP–BNNT, (d) and (f) the higher magnification SEM images in (c) and (e) marked with red square (f) AFM (upper) and TEM (lower) images. Figure adapted with permission from [90], copyright 2013 Elsevier.
Figure 9Schematic representation of a poly-L-lysine-, fluorescent probe- and folate-modified BNNT. Figure adapted with permission from the authors [97].